Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Raymer

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Expert Opinion on Therapeutic Patents|July 16, 2015
Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014)Brian Raymer, David Ebner
Journal of Medicinal Chemistry|July 28, 2018
Lead-like Drugs: A PerspectiveBrian Raymer, Samit K Bhattacharya
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylaseBrian Raymer, Michael Kavana, Allen Price, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2007
Total synthesis of (+)-azaspiracid-1. Part I: Synthesis of the fully elaborated ABCD aldehydeDavid A Evans, Lisbet Kvaernø, Jason A Mulder, et al.
Journal of the American Chemical Society|November 14, 2008
Total synthesis of (+)-azaspiracid-1. An exhibition of the intricacies of complex molecule synthesisDavid A Evans, Lisbet Kvaernø, Travis B Dunn, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2007
Total synthesis of (+)-azaspiracid-1. Part II: synthesis of the EFGHI sulfone and completion of the synthesisDavid A Evans, Travis B Dunn, Lisbet Kvaernø, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2018
Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9Allyn T Londregan, Gary Aspnes, Chris Limberakis, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2023
Small molecule inhibitors of PCSK9. SAR investigations of head and amine groupsGary E Aspnes, Steven B Coffey, Etzer Darout, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of FructoseKentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Expert Opinion on Therapeutic Patents|July 16, 2015
Small molecule and peptide therapies for chronic heart failure: a patent review (2011 - 2014)Brian Raymer, David Ebner
Journal of Medicinal Chemistry|July 28, 2018
Lead-like Drugs: A PerspectiveBrian Raymer, Samit K Bhattacharya
Bioorganic & Medicinal Chemistry Letters|April 11, 2009
Synthesis and characterization of a BODIPY-labeled derivative of Soraphen A that binds to acetyl-CoA carboxylaseBrian Raymer, Michael Kavana, Allen Price, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2007
Total synthesis of (+)-azaspiracid-1. Part I: Synthesis of the fully elaborated ABCD aldehydeDavid A Evans, Lisbet Kvaernø, Jason A Mulder, et al.
Journal of the American Chemical Society|November 14, 2008
Total synthesis of (+)-azaspiracid-1. An exhibition of the intricacies of complex molecule synthesisDavid A Evans, Lisbet Kvaernø, Travis B Dunn, et al.
Angewandte Chemie (International Ed. in English)|June 5, 2007
Total synthesis of (+)-azaspiracid-1. Part II: synthesis of the EFGHI sulfone and completion of the synthesisDavid A Evans, Travis B Dunn, Lisbet Kvaernø, et al.
Bioorganic & Medicinal Chemistry Letters|November 29, 2018
Discovery of N-(piperidin-3-yl)-N-(pyridin-2-yl)piperidine/piperazine-1-carboxamides as small molecule inhibitors of PCSK9Allyn T Londregan, Gary Aspnes, Chris Limberakis, et al.
Bioorganic & Medicinal Chemistry Letters|June 28, 2023
Small molecule inhibitors of PCSK9. SAR investigations of head and amine groupsGary E Aspnes, Steven B Coffey, Etzer Darout, et al.
Journal of Medicinal Chemistry|September 10, 2020
Discovery of PF-06835919: A Potent Inhibitor of Ketohexokinase (KHK) for the Treatment of Metabolic Disorders Driven by the Overconsumption of FructoseKentaro Futatsugi, Aaron C Smith, Meihua Tu, et al.
Angewandte Chemie (International Ed. in English)|October 27, 2017
Liver-Targeted Small-Molecule Inhibitors of Proprotein Convertase Subtilisin/Kexin Type 9 SynthesisKim F McClure, David W Piotrowski, Donna Petersen, et al.
Pageof 2